Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

CUSIP: 185063104

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
76,991,404
Total 13F shares
16,371,849
Share change
-4,635,971
Total reported value
$37,492,487
Put/Call ratio
229%
Price per share
$2.29
Number of holders
58
Value change
-$12,563,251
Number of buys
23
Number of sells
34

Quarterly Holders Quick Answers

What is CUSIP 185063104?
CUSIP 185063104 identifies CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q1 2022

As of 31 Mar 2022, Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,371,849 shares. The largest 10 holders included Carmignac Gestion, ACT CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Inc., MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, Assenagon Asset Management S.A., RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA ADVISERS, LP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 58 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.